News

This orphan medicinal product designation qualifies Tengion and its Neo-Bladder augment for European Medicines Agency (EMEA) regulatory incentives, including eligibility for protocol assistance and possible exemptions or reductions

AstraZeneca has been working with the FDA in the investigation of the safety and effectiveness of Casodex in a pediatric setting but will not be seeking an indication

The agreement leading to the improved offer was unanimously approved by the board of directors of Zentiva, and the board has recommended that Zentiva shareholders tender their shares

The Phase I, open-label, dose escalation study is evaluating the safety, tolerability, and pharmacokinetics of a single intravitreal injection of iCo-007 in patients with diffuse diabetic macular edema

CytRx has purchased Innovive for a total consideration of approximately 2.6 million shares of CytRx common stock, approximately $18.3 million of future performance-based milestone earn-outs, and the assumption

CryoLife has started distributing Hemostase MPH in the US, the UK and Germany in the second quarter of 2008. Distribution will continue to expand to additional markets later

This trial is expected to be the first of two pivotal Phase III trials required to support filing for regulatory approval for Gammagard Liquid as a potential treatment

The study, which will be used to support the filing with health authorities worldwide, includes more than 1,100 patients between 51 and 80 years old with a medical

Carbidopa and Levodopa orally disintegrating tablets (ODT), indicated for the treatment of idiopathic Parkinson’s disease, are the generic version of Schwarz Pharma’s Parcopa ODT. This product, which Mylan